$ACRV
Acrivon Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Watertown, MA
ACRV chart
What traders are saying about $ACRV
Latest postsAcrivon Therapeutics, Inc. news
- An automatic tax-withholding sale covers 513 shares of Acrivon Therapeutics (ACRV).
Stock Titan ·
- Acrivon unveils CDK11 inhibitor ACR-7280 for acute myeloid leukemia
BioWorld News ·
- Acrivon Advances ACR-7280, an Optimized, AP3-Enabled, Potential First-in-Class, Oral CDK11 Inhibitor Toward IND Filing in First Half of 2027
Yahoo Finance ·
- What Makes Acrivon Therapeutics, Inc. (ACRV) a New Buy Stock
Yahoo Finance ·
- Acrivon Therapeutics, Inc. (ACRV) Just Flashed Golden Cross Signal: Do You Buy?
Yahoo Finance ·
- Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference
Yahoo Finance ·
- Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer
Yahoo Finance ·
- Here's Why Acrivon Therapeutics, Inc. (ACRV) is a Great Momentum Stock to Buy
Yahoo Finance ·
- Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 2026 Clinical Data Catalysts
Yahoo Finance ·
- Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study
Yahoo Finance ·
- Acrivon to Highlight the Power of its AP3 Platform for Streamlined, Pathway-Based Drug Discovery and Development with Oral and Poster Presentations at AACR D3 Conference
Yahoo Finance ·
- Acrivon Therapeutics to Present at TD Cowen’s 7th Annual Oncology Innovation Summit
Yahoo Finance ·
Acrivon Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$77.9M | -$80.6M | -$60.4M | -$31.2M |
| Diluted EPS | $-2.02 | $-2.38 | $-2.74 | $-7.56 |
| Total assets (year end) | $129.7M | $196.6M | $138.3M | $181.2M |
| Cash and equivalents (year end) | $41.5M | $39.8M | $36.0M | $29.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Acrivon Therapeutics, Inc.
- Ticker
- ACRV (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Watertown, MA
- Fiscal year end
- December 31
- SEC CIK
- 1781174
Frequently asked questions
What exchange is Acrivon Therapeutics, Inc. listed on?
Acrivon Therapeutics, Inc. trades on the Nasdaq under the ticker symbol ACRV.
What industry is Acrivon Therapeutics, Inc. in?
Acrivon Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Acrivon Therapeutics, Inc. headquartered?
Acrivon Therapeutics, Inc.'s business address on file with the SEC is in Watertown, MA.
When does Acrivon Therapeutics, Inc.'s fiscal year end?
Acrivon Therapeutics, Inc.'s fiscal year ends on December 31.